Scope of practice in UK aesthetics is determined by three converging frameworks: professional registration with a statutory regulator, individual clinical training and documented competence, and the legal classification of the procedure being performed. Where all three align, a practitioner can lawfully proceed. Where any one is absent, they cannot.
What Scope of Practice Means in Aesthetic Practice
Scope of practice is not a fixed list handed down by a single authority. It is the boundary of what a particular practitioner, at a particular point in their career, can safely and lawfully perform based on their training, their registration status, and the regulatory requirements that attach to the treatment in question.
For aesthetic practitioners in the UK, that boundary is shaped by multiple overlapping frameworks, none of which operates alone.
Professional registration. Nurses hold NMC registration. Doctors hold GMC registration. Dentists hold GDC registration. Pharmacists hold GPhC registration. Each statutory regulator sets professional standards that define the outer limit of what its registrants can do. Working outside those standards is a fitness-to-practise matter, not an administrative oversight.
Clinical competence. Registration alone does not authorise a treatment. A registered nurse who has never trained in botulinum toxin injection is not within scope to perform it. Competence must be documented, evidence-based, and current. The fact of holding a nursing or medical degree does not confer competence in specific aesthetic procedures.
Treatment classification. Some aesthetic treatments involve prescription-only medicines. Some involve medical devices regulated by the MHRA. Some are unclassified procedures with no statutory entry requirement but significant clinical risk. Where a treatment involves a POM, the prescription chain introduces an additional scope requirement that applies regardless of the practitioner's registration or clinical background.
The JCCP and CPSA Code of Practice frames scope of practice as a standing obligation, not a one-time assessment. Practitioners are expected to maintain the competence they claim, to recognise the limits of that competence, and to decline treatments that fall outside what their training, registration, and clinical governance can support.
Nurses in Aesthetics: What the NMC Framework Permits
The NMC Code is the baseline standard for every registered nurse in the UK, in every clinical setting, including independent aesthetic practice. Its provisions on competence and scope are direct.
The Code requires nurses to recognise and work within the limits of their competence. It instructs registrants to keep their knowledge and skills up to date and to deliver care based on the best available evidence. These are not aspirational statements. They are professional standards that apply to every treatment decision.
For nurses in aesthetics, the Code's scope provisions translate into several practical requirements.
Training before practice. A nurse must have completed appropriate, structured training in any treatment before delivering it. The Code does not specify the exact format or provider; it requires competence. The JCCP Code of Practice gives more granular guidance on what training standards look like for the purposes of practitioner listing.
Maintained competence. Training completed in 2018 and not refreshed does not satisfy the NMC's competence standard in 2026. Volume of practice, CPD, and demonstrated ongoing skill all contribute to maintained competence. A nurse who has not performed a procedure regularly, or has not updated their knowledge to reflect evidence changes, should audit their position before continuing to offer that treatment.
Prescribing versus administering. A registered nurse without an independent prescribing qualification cannot prescribe prescription-only medicines. They can administer a POM under a valid prescription issued by an authorised prescriber who has personally assessed the patient, but the prescribing authority does not belong to them. An aesthetic nurse who administers botulinum toxin or hyaluronidase must hold a valid prescription from a face-to-face prescriber. Following the remote prescribing ban confirmed by the NMC in 2025, that prescriber must have seen the patient in person. Remote, telephone, or video consultations do not satisfy the requirement.
Refusal as a scope tool. Where a patient presents with a clinical picture that falls outside the nurse's training, or involves a medicine or device the nurse is not competent to manage safely, declining to treat is the correct scope response. The Code supports this. A nurse who proceeds with a treatment outside their competence to avoid an awkward conversation with the patient is not operating in scope; they are making a clinical governance choice with potential fitness-to-practise consequences.
Medical Practitioners and Dentists in Aesthetic Practice
Doctors registered with the GMC bring a different baseline to aesthetic practice. Medical training provides a broad clinical foundation, but it does not automatically confer competence in aesthetic procedures. The GMC's standards make this explicit: competence in a specific area requires specific training and maintained skills in that area.
The GMC's guidance on prescribing and managing medicines requires doctors to prescribe only where they are satisfied it is safe to do so: that the patient has been personally assessed, the medicine is appropriate for the individual, and any interaction risks have been considered. This applies fully in aesthetic prescribing contexts. A doctor prescribing botulinum toxin for a patient they have not examined in person falls outside GMC prescribing standards, regardless of their registration.
For dentists, GDC registration covers procedures within the mouth and surrounding structures. Perioral aesthetics, including botulinum toxin injections and dermal filler treatments in the perioral region, sit within a scope that GDC registrants can access with appropriate training. Treatments further across the face, or non-surgical procedures with no dental connection, are not automatically within a dental practitioner's scope by virtue of GDC registration. The same competence-based test applies: relevant training, maintained skills, and clinical governance that supports the work being done.
Across all three registered healthcare professions, nurses, doctors, and dentists, the pattern is consistent. Registration is necessary but not sufficient. It opens access to a range of activities. Training and documented competence determine which ones the practitioner can legitimately perform.
Non-Registered Practitioners: Legal Position Under the Licensing Scheme
A significant number of people working in aesthetics in the UK are not registered with a statutory healthcare regulator. They may hold training qualifications and be capable practitioners, but they do not hold NMC, GMC, GDC, or GPhC registration.
For these practitioners, scope of practice is not defined by a professional code. It is defined by the legal classification of the treatments they perform and by England's licensing scheme.
Under the Health and Care Act 2022, which introduced statutory licensing for non-surgical cosmetic procedures in England, treatment tiers carry different requirements.
Green-tier treatments (lower-risk non-invasive procedures including microneedling, superficial chemical peels, and laser hair removal) are accessible to non-registered practitioners with a basic local authority licence, appropriate training, and indemnity. No requirement for clinical oversight from a registered healthcare professional is imposed at the tier level.
Amber-tier treatments (botulinum toxin, dermal fillers, PRP) require that non-registered practitioners work under the oversight of a named, regulated healthcare professional. That person must have a genuine governance role, not a nominal one. The oversight arrangement must be documented and evidenceable. As the July 2026 licensing update made clear, the framework now exists for inspection and enforcement of this requirement.
Red-tier procedures are restricted to regulated healthcare professionals practicing within CQC-registered premises. Non-registered practitioners do not fall within scope for red-tier procedures.
The amber-tier oversight requirement is the practical boundary that most non-registered aesthetic practitioners encounter. Working in this tier without a documented, genuine oversight arrangement is not a compliance paperwork gap. It is working outside the legal framework that governs those treatments.
Prescription-Only Medicines and Scope of Practice
Botulinum toxin is a prescription-only medicine under the Human Medicines Regulations 2012. Hyaluronidase, used to dissolve hyaluronic acid filler, is also a POM. Local anaesthetics above certain concentrations are POMs. The prescription chain for these medicines is a scope-defining layer that applies to every practitioner who uses them, regardless of registration status.
The prescription must come from an authorised prescriber: an independent nurse prescriber, a doctor, a dentist within their relevant scope, or a pharmacist prescriber. That prescriber must have personally assessed the patient before issuing the prescription. No exceptions exist for cosmetic use. The remote prescribing ban confirmed by the NMC in 2025 makes this clear across the NMC, GMC, and JCCP.
Where a non-prescribing practitioner administers a POM under a prescription, the validity of that prescription is load-bearing. If the prescription was not lawfully issued, the entire treatment falls outside the legal framework, and responsibility flows to both the prescriber who issued it and the practitioner who administered it.
Practitioners should hold written confirmation that their prescriber assesses each patient in person before issuing a prescription. The JCCP Code of Practice requires oversight arrangements to be documented. Verbal agreements and informal understandings do not satisfy the standard.
What Working Within Scope Requires in Practice
Scope of practice is not a static credential. It is a living standard that requires active maintenance. Practitioners who trained several years ago and have not updated their skills, reviewed changes in clinical evidence, or refreshed their complication management competencies may be practicing at the edge of scope without recognising it.
The practical requirements for maintaining scope consistently include the following.
A training record that holds. Every treatment in a practitioner's list should be traceable to a training event with a verifiable provider, a clear date, and a record of what was covered. Training at Level 7 for injectable procedures is the standard the regulation framework is converging on for amber-tier treatments. Where training falls below that level, practitioners face a growing compliance gap, not a theoretical one.
A competence log, not just a certificate. Training is an input. Competence is an output. A log that shows ongoing practice volume, CPD, reflective accounts from clinical experience, and adverse event review demonstrates maintained scope. A certificate with no further record of practice does not.
Complication management being in scope. Practitioners who offer treatments must be capable of managing the complications of those treatments. Offering botulinum toxin without vascular anatomy training, or offering filler without hyaluronidase access and the clinical competence to use it, is a scope problem. The JCCP Code of Practice treats emergency preparedness as a clinical standard, not an optional addition.
The ability to say no. A sound approach to scope includes a clear process for declining treatments that fall outside what the practitioner can safely offer. Referral pathways for patients who need different clinical input are part of the scope framework, not a sign of limitation. A practitioner who can articulate what falls outside their scope demonstrates clinical governance. A practitioner who never declines any treatment raises a different question.
How the Licensing Scheme Changes Scope Expectations
The Health and Care Act 2022 has shifted scope of practice from a professional expectation to a legally inspectable standard. The three-tier licensing classification is, in practical effect, a statutory scope framework. It defines what each category of practitioner can do, under what conditions, and in what settings.
For practitioners used to operating in a sector without formal external inspection, this represents a material change. The amber-tier oversight requirement, the CQC registration requirement for red-tier premises, and the local authority licensing infrastructure together create a structure where practicing outside scope is not only a professional risk. It carries licensing consequences.
Practitioners who have built clear training records, maintained competence documentation, and established governance arrangements are positioned to demonstrate their scope to an inspector. Those who have not are at both clinical and regulatory risk.
The JCCP register remains the most widely cited evidence of practitioner-level compliance with the standards the licensing scheme is converging on. Holding registration and keeping the supporting evidence current is not a credential to collect. It is the ongoing demonstration that scope is being actively managed.
Scope questions that practitioners could not answer clearly two years ago now have consequences attached to the wrong answer. The question is not whether to engage with this framework. It is whether to engage before or after an inspection.
From Regulation to Reputation™ is £200 off until 20 July, £299 instead of £499, with code REG299. Bernadette wrote the book on this subject, Regulation to Reputation: mastering successful aesthetic practice, and the course is the four-week programme built on that work. It covers scope of practice, the prescribing framework, clinical governance, and the documentation standards that keep a practice operating within the framework as the regulations develop. See the full course catalogue.
FAQ
Does a nurse need a prescribing qualification to administer Botox?
A nurse who administers botulinum toxin must do so under a valid prescription from an authorised prescriber. If the nurse does not hold an independent prescribing qualification, that prescription must come from a doctor, dentist, or nurse prescriber who has personally assessed the patient. A nurse without prescribing rights can administer under a valid prescription; they cannot prescribe.
Can a non-registered practitioner perform aesthetic treatments in England?
Yes, within limits. Non-registered practitioners can perform green-tier procedures with a local authority licence, appropriate training, and indemnity. For amber-tier treatments, including botulinum toxin, dermal fillers, and PRP, they must work under the documented oversight of a named regulated healthcare professional. Red-tier procedures are restricted to registered healthcare professionals only.
What are the consequences of practicing outside scope?
For registered healthcare professionals, practicing outside scope is a fitness-to-practise matter with their statutory regulator: the NMC for nurses, the GMC for doctors, the GDC for dentists. Under England's licensing scheme, it also carries licensing consequences. Indemnity claims related to treatments outside the practitioner's demonstrated competence may face challenge. The risks are professional, regulatory, and financial simultaneously.
Does a Level 7 qualification define scope for injectable treatments?
Level 7 is the standard the professional bodies and the licensing framework are converging on for injectable and higher-risk procedures. It is not currently a universal statutory requirement for every treatment, but it is the level that JCCP listing, many indemnity providers, and amber-tier oversight arrangements expect. Practitioners without Level 7 training for injectables face a growing compliance gap, not a future one.
How does the JCCP Code define scope of practice?
The JCCP Code of Practice requires practitioners to work within their training and competence, to document that training, to maintain it through CPD, and to decline treatments that fall outside their demonstrated skills. The Code treats scope as an active clinical standard with specific requirements for training records, complication management competence, and emergency preparedness. See the regulation overview for how the JCCP framework fits the wider licensing landscape.